nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbetocin—OXTR—Oxytocin signaling—CD38—acquired immunodeficiency syndrome	0.482	0.583	CbGpPWpGaD
Carbetocin—OXTR—blood—acquired immunodeficiency syndrome	0.0344	0.198	CbGeAlD
Carbetocin—OXTR—spinal cord—acquired immunodeficiency syndrome	0.0331	0.191	CbGeAlD
Carbetocin—OXTR—lung—acquired immunodeficiency syndrome	0.0302	0.173	CbGeAlD
Carbetocin—OXTR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0283	0.0342	CbGpPWpGaD
Carbetocin—OXTR—nervous system—acquired immunodeficiency syndrome	0.0279	0.161	CbGeAlD
Carbetocin—OXTR—central nervous system—acquired immunodeficiency syndrome	0.0269	0.155	CbGeAlD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0219	0.0266	CbGpPWpGaD
Carbetocin—OXTR—brain—acquired immunodeficiency syndrome	0.0213	0.123	CbGeAlD
Carbetocin—OXTR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0158	0.0191	CbGpPWpGaD
Carbetocin—OXTR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0149	0.018	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0147	0.0178	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.0136	0.0164	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.0133	0.0161	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.012	0.0146	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0112	0.0136	CbGpPWpGaD
Carbetocin—OXTR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.0102	0.0123	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00892	0.0108	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00821	0.00994	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00807	0.00976	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00743	0.00899	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00698	0.00845	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00698	0.00845	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00679	0.00822	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00614	0.00743	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00582	0.00704	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00575	0.00696	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00551	0.00667	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00547	0.00662	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00531	0.00643	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00498	0.00603	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00479	0.00579	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00468	0.00567	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00468	0.00567	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0042	0.00508	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00379	0.00459	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00375	0.00454	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00357	0.00432	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00357	0.00432	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00356	0.00431	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00349	0.00422	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0034	0.00411	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00321	0.00389	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00315	0.00382	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00271	0.00329	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00245	0.00296	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00215	0.00261	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00214	0.0026	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00206	0.00249	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00206	0.00249	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00202	0.00244	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00202	0.00244	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00195	0.00236	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.00191	0.00232	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00186	0.00225	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00183	0.00222	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00183	0.00222	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00153	0.00186	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00151	0.00183	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00147	0.00178	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00139	0.00169	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00138	0.00167	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00137	0.00166	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00127	0.00154	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00125	0.00152	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00115	0.00139	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00108	0.00131	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00108	0.00131	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000823	0.000996	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00081	0.000981	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000798	0.000966	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000741	0.000897	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000725	0.000878	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000428	0.000518	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000426	0.000516	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000252	0.000305	CbGpPWpGaD
